Molecular Pathology, Diagnostics, and Therapeutics

Special Issues

Following special issues within this section are currently open for submissions:

• Roles and Mechanisms of Non-Coding RNAs in Breast Cancer (Deadline: 20 August 2026)
• Extracellular Vesicles (EVs) in Cancer Progression and Metastasis: Molecular Insights and Clinical Outlook (Deadline: 20 August 2026)
• Molecular Imaging for Cancer Theranostics (Deadline: 20 August 2026)
• The Role of Extracellular Histones in Patho(physio)logical Hemostasis (Deadline: 20 August 2026)
• Cognitive Aging: Molecular Perspectives (Deadline: 20 August 2026)
• The Impact of Cancer–Immune Cell Crosstalk on Diagnosis, Prognosis and Treatment (Deadline: 20 August 2026)
• Ferroptosis and Cuproptosis: Mechanism and Crosstalk in Cancer, Neurodegeneration, and Metabolic Syndrome (Deadline: 20 August 2026)
• Molecular Insights into Innovative Materials and Procedures for Implant and Prosthodontics (Deadline: 20 August 2026)
• Molecular Research in Asthma and Allergy (Deadline: 20 August 2026)
• Molecular Mechanisms of Neutrophil Extracellular Traps (Nets) in Human Diseases (Deadline: 20 August 2026)
• Early Diagnosis and Advanced Therapies of Genetic Disorders (Deadline: 20 August 2026)
• Molecular Pathophysiology and Treatments of Diabetes (Deadline: 20 August 2026)
• Intestinal Diseases and Gut Microbiota (Deadline: 20 August 2026)
• Molecular Aspects of Diabetes and Its Complications (Deadline: 20 August 2026)
• Molecular Mechanisms and Therapeutic Strategies for Pregnancy Complications (Deadline: 20 August 2026)
• Molecular Research on Embryo Developmental Potential: 2nd Edition (Deadline: 20 August 2026)
• Kidney Disease: Molecular Insights and Emerging Therapies (Deadline: 20 August 2026)
• Cellular Physiology and Aging: Membrane Dynamics, Intracellular Environment and Signaling Pathways (Deadline: 20 August 2026)
• Recent Advances in Molecular and Cellular Approaches to Tuberculosis Pathogenesis, Treatment and Prevention (Deadline: 20 August 2026)
• Molecular Mechanisms and Combinatorial Strategies in Anti-Obesity Therapeutics (Deadline: 20 August 2026)
• Epilepsy: Exploring the Molecular Mechanisms and Potential Medications (Deadline: 20 August 2026)
• Study of the Molecular Mechanisms Underlying the Involvement of Viruses in the Progression of Autoimmune Diseases (Deadline: 20 August 2026)
• Recent Advances in Molecular Imaging and Therapy (Deadline: 20 August 2026)
• Pregnancy-Related Complications: Molecular Pathogenesis and Therapeutic Strategies (Deadline: 20 August 2026)
• Targeting Epilepsy: Molecular Mechanisms, Neuroinflammation and Emerging Therapies (Deadline: 20 August 2026)
• Long COVID Biology and Epidemiology: Predisposition, Molecular Mechanisms and Diagnostics (Deadline: 20 August 2026)
• Peripheral Neuropathy: Exploring Pathogenic Pathways and Therapeutic Approaches (Deadline: 20 August 2026)
• Photosensitizers for Photodynamic Therapy: From Molecular Design to Application (Deadline: 20 August 2026)
• Molecular Insight into Oral Health: Disease and Medicine (Deadline: 20 August 2026)
• MicroRNAs as Biomarkers in Chronic Diseases (Deadline: 20 August 2026)
• Engineered Mesenchymal Stromal/Stem Cells: Increasing Targeting Precision in Cancer Therapy (Deadline: 20 August 2026)
• Hearing Loss: Molecular Biological Insights, 2nd Edition (Deadline: 20 August 2026)
• Unraveling Synaptic Structure and Function in the Healthy and Diseased Brain (Deadline: 20 August 2026)
• Molecular Mechanisms of Vascular Sclerosis (Deadline: 20 August 2026)
• Molecular Advances in Heart Disease: Genomics and Bioinformatics of Heart Research—2nd Edition (Deadline: 20 August 2026)
• Vitamin D in Reproductive Disorders: Determinants, Metabolism, and Downstream Biological Mechanisms (Deadline: 20 August 2026)
• Endometriosis: Focusing on Molecular and Cellular Research, 2nd Edition (Deadline: 30 August 2026)
• Cardioprotective Mechanisms in Myocardial Ischemia (Deadline: 30 August 2026)
• Molecular Pathophysiology of Lung Diseases—2nd Edition (Deadline: 30 August 2026)
• Exploring the Genetics in Rare Diseases: A Genomic Odyssey (Deadline: 31 August 2026)
• The Placental Barrier: From Fundamental Mechanisms to Clinical Implications (Deadline: 31 August 2026)
• Cardiovascular Diseases: From Molecular Diagnosis to Treatment (Deadline: 31 August 2026)
• Molecular Mechanisms in Cardiovascular and Metabolic Diseases: Effective and Potential Treatments (Deadline: 31 August 2026)
• Hydrogen Medicine: From Molecular Insights to Disease Intervention (Deadline: 31 August 2026)
• Molecular Insights in Placental Function and Pregnancy Complications (Deadline: 31 August 2026)
• Oral and Esophageal Disorders: Molecular Induction/Promotion, Treatment, and Prevention (Deadline: 31 August 2026)
• Molecular Mechanisms, Biomarkers, and Therapeutic Targets in Heart Failure (Deadline: 31 August 2026)
• Emerging Biomarkers in Airway Diseases: From Epigenetic Regulation to Cellular Stress Pathways (Deadline: 31 August 2026)
• Molecular Mechanisms and Advanced Diagnostic Technologies in Hair Disorders (Deadline: 31 August 2026)
• Molecular Atlas of Cardiac Development and Diseases (Deadline: 31 August 2026)
• Molecular Targets in Reproductive Diseases (Deadline: 31 August 2026)
• Advanced Molecular Research on Kidney Diseases (Deadline: 31 August 2026)
• Periodontitis: From Cellular Mechanism to Therapy (Deadline: 31 August 2026)
• Glaucoma: From Molecular Mechanisms to Innovative Therapeutics (Deadline: 31 August 2026)
• Kidney Transplantation: Current Framework and New Perspectives (Deadline: 31 August 2026)
• Molecular Pathways Shaping Therapeutic Vulnerability in Leukaemia (Deadline: 31 August 2026)
• The Exhaustive Chase: Investigation of Striated Muscle Regulation in Health and Disease (Deadline: 31 August 2026)
• Recent Advances in Pathophysiology and Immunology Related to Lung Cancer (Deadline: 31 August 2026)
• Molecular Studies of Endothelial Dysfunction (Deadline: 31 August 2026)
• Research on Host–Oral Bacteria Interactions in Periodontal Pathogenesis (Deadline: 31 August 2026)
• Tissue Regeneration Mechanisms and Applications in Degenerative and Inflammatory Diseases (Deadline: 31 August 2026)
• The Role of Endocrine Disruptors in Cancer (Deadline: 31 August 2026)
• Molecular Mechanisms of Endothelial Dysfunction, Fifth Edition (Deadline: 31 August 2026)
• Cellular and Molecular Progression of Cardiovascular Diseases: 2nd Edition (Deadline: 10 September 2026)
• Exercise in Health and Diseases: From the Molecular Perspectives (Deadline: 10 September 2026)
• Exploring the Complex Interplay Between Metabolic Diseases, MASLD, and Liver Cancer (Deadline: 20 September 2026)
• Renin-Angiotensin System in Health and Diseases (Deadline: 20 September 2026)
• Cellular Plasticity in Health and Diseases (Deadline: 20 September 2026)
• Molecular Studies of Bone Biology and Bone Tissue: 2nd Edition (Deadline: 20 September 2026)
• Autophagy and Viral Infections: The Era of New Therapeutical Strategies (Deadline: 20 September 2026)
• Molecular Research of Dystonia and Parkinson’s Disease (Deadline: 20 September 2026)
• Gluten/Wheat-Related Disorders: The Role of Nutrition, Gut Barrier, Microbiota, and New Therapeutic Strategies (Deadline: 20 September 2026)
• Novel Insights into the Molecular Mechanisms of Pancreatitis (Deadline: 20 September 2026)
• Advances in Vitiligo: From Mechanisms to Treatment Innovations (Deadline: 20 September 2026)
• Cellular and Molecular Study of Neurodevelopmental and Neurological Disorders (Deadline: 20 September 2026)
• Melanoma: Molecular Diagnosis and Treatment (Deadline: 20 September 2026)
• Molecular Advances in Regenerative Medicine and Therapeutics (Deadline: 20 September 2026)
• Molecular Pathways and Mechanisms of Lung Injury: From Environmental Agents to Clinical Implications (Deadline: 20 September 2026)
• Molecular Insights into Heart Failure: From Bench to Bedside (Deadline: 20 September 2026)
• Recent Progress in Biological and Molecular Mechanisms and Targeted Therapies of Leukemia (Deadline: 20 September 2026)
• Molecular Pharmacology and Interventions in Cardiovascular Disease: 2nd Edition (Deadline: 20 September 2026)
• Molecular Targets in Alzheimer’s Disease: From Mechanisms to Therapeutic Strategies (Deadline: 20 September 2026)
• Identification of Novel Biomarkers Towards Improved Diagnosis and Management of Peripheral Vascular Diseases (Deadline: 20 September 2026)
• Vitamin K in Disease Mechanisms and Therapy (Deadline: 20 September 2026)
• Molecular Mechanisms and Targeted Therapy of Lymphedema and Lipedema (Deadline: 20 September 2026)
• Health Impacts of Environmental Pollution on the Urogenital and Reproductive Systems (Deadline: 20 September 2026)
• Molecular Research on Zoonotic Diseases: Current Advances and Perspectives (Deadline: 20 September 2026)
• Molecular, Cellular Mechanism of Oxidative Stress in Physiological and Pathophysiological Conditions, 2nd Edition (Deadline: 20 September 2026)
• Pain: From Bench to Bedside (Deadline: 20 September 2026)
• Strategies for Enhancing Skeletal Muscle Recovery and Regeneration in Health and Disease Conditions (Deadline: 20 September 2026)
• Molecular Research on Prostate Cancer, 2nd Edition (Deadline: 20 September 2026)
• Kidney Diseases: Molecular Research and Novel Therapies (Deadline: 20 September 2026)
• Advances in Nasopharyngeal Carcinoma Immunology, Epigenetics, and Therapy (Deadline: 20 September 2026)
• Molecular Advances in Gestational Diabetes Mellitus: 2nd Edition (Deadline: 20 September 2026)
• Female and Male Fertility: From Diseases to Current Trends and Research Developments (Deadline: 20 September 2026)
• Oral Diseases: Molecular Research and Novel Therapy (Deadline: 20 September 2026)
• Molecular Diagnostics and Therapeutic Targets in Bladder Cancer (Second Edition) (Deadline: 20 September 2026)
• Molecular Advances in Retinal Degeneration (Deadline: 20 September 2026)
• Skin Diseases: From Molecular Mechanisms to Pathology, 2nd Edition (Deadline: 20 September 2026)
• Neutrophil Extracellular Traps (NETs) in Human Disease: From Molecular Mechanisms to Therapeutic Translation (Deadline: 20 September 2026)
• Environmental Exposures and Emerging Mechanisms in Chronic Obstructive Pulmonary Disease: From Pathogenesis to Precision Therapeutics (Deadline: 20 September 2026)
• Pathophysiology and Molecular Mechanisms of Cardiovascular, Cardiometabolic, and Cardiorenal Diseases (Deadline: 20 September 2026)
• Oral and Dental Infectious Diseases: Molecular Pathology, Diagnosis and Therapy (2nd Edition) (Deadline: 20 September 2026)
• New Trends in Diabetes, Hypertension and Cardiovascular Diseases: 4th Edition (Deadline: 20 September 2026)
• Molecular Signatures for Risk Stratification and Therapeutic Decision-Making in Primary and Recurrent Prostate Cancer (Deadline: 20 September 2026)
• Molecular Mechanisms and Biomarkers in Cardiovascular Disease: Hepatocardiac and Systemic Interactions (Deadline: 20 September 2026)
• Molecular Mechanisms, Pathogenesis, and Novel Therapeutic Strategies in Cardiovascular Disease, 2nd Edition (Deadline: 20 September 2026)
• Molecular and Cellular Mechanisms in Cardiovascular Disease (Deadline: 20 September 2026)
• Optical, Raman, and Pathological Imaging Biomarkers for Diagnosis and Therapy (Deadline: 20 September 2026)
• Unraveling the Molecular Landscape of Systemic Lupus Erythematosus (Deadline: 20 September 2026)
• Natural Product-Based Therapeutics: Molecular Mechanisms and Cellular Modulation (Deadline: 20 September 2026)
• Down Syndrome: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 20 September 2026)
• Gastrointestinal Diseases and Pharmacology (Deadline: 20 September 2026)
• Cardiovascular Disease: Molecular Basis and Treatment Strategies (Deadline: 20 September 2026)
• Breakthroughs in Diagnostic Prediction and Fundamental Therapeutics of Dementia and Movement Disorders, 3rd Edition (Deadline: 25 September 2026)
• Molecular Mechanisms in Forensic Pathology (Deadline: 29 September 2026)
• Advancements and Applications of Phyto-Nanotherapy in Targeted Disease Treatment (Deadline: 30 September 2026)
• New Insights into Epilepsy: From Molecular Physiology to Pathology (Deadline: 30 September 2026)
• Advancing Liver Health: State of the Art and Recent Research Advances (Deadline: 30 September 2026)
• Mesenchymal Stem/Stromal Cells: Mechanisms and Applications in Tissue Regeneration (Deadline: 30 September 2026)
• Genetic, Functional and Therapeutic Aspects of Procoagulant and Anticoagulant Factors (Third Edition) (Deadline: 30 September 2026)
• Molecular, Genetic, and Omics Approaches to Disorders in Bone–Inflammation Crosstalk (Deadline: 30 September 2026)
• Cardiomyocytes Among Physiology and Pathophysiology: Molecular Insights and Therapeutic Implications (Deadline: 30 September 2026)
• Common Mechanisms in Gestational Diabetes, Preeclampsia, and Coronavirus Disease 2019 (Deadline: 30 September 2026)
• Research on Immune Mechanisms in Kidney Disease (Deadline: 30 September 2026)
• Exploring UV-Induced Disease: Insights into Mechanisms and Innovative Strategies for Prevention and Therapy (Deadline: 30 September 2026)
• Molecular Mechanisms Driving Liver Disease: From Cellular Stress to Therapeutic Targets (Deadline: 30 September 2026)
• Molecular Mechanism in Cardiac Remodeling (Deadline: 30 September 2026)
• Oral Squamous Cell Carcinoma: From Pathogenesis to Targeted Therapy (Deadline: 30 September 2026)
• The Molecular Landscape of Endometrial and Ovarian Dysfunction in Polycystic Ovary Syndrome: Insights into Disease Mechanisms (Deadline: 30 September 2026)
• Molecular Mechanism, Pathogenesis, and Precision Therapeutics in Thyroid Cancer (Deadline: 30 September 2026)
• Procoagulant Platelets in Vascular Disease and Beyond (Deadline: 30 September 2026)
• Genetics and Molecular Therapies in Common Age-Related and Inherited Retinal Diseases (Deadline: 30 September 2026)
• Cardiac Protein Metabolism in Health and Diseases (Deadline: 30 September 2026)
• Multifactorial Aspects of Hypertension: Advances and Challenges (Deadline: 30 September 2026)
• Emerging Trends in the Diagnosis and Treatment of Hematologic Disorders (Deadline: 30 September 2026)
• Molecular Determinants of Cardiovascular Diseases (Deadline: 30 September 2026)
• Biomarkers and Mechanisms Guiding Precision Therapy in Lung Cancer (Deadline: 30 September 2026)
• Molecular Pathogenesis of Age-Related Ocular Diseases and Existing Therapies (Deadline: 30 September 2026)
• Targeting Metabolism, Inflammation, and Oxidative Stress: Novel Therapeutic Approaches in Human Diseases (Deadline: 30 September 2026)
• Cell Therapies: Cellular Mechanisms and Genetic Engineering (Deadline: 30 September 2026)
• Novel Molecular Pathways and Therapeutic Strategies in Atherosclerotic Cardiovascular Disease (Deadline: 30 September 2026)
• Pathogenic Escherichia coli: Cellular Biology, Mechanisms of Pathogenesis, Therapeutic Approaches and Strategies for Disease Intervention (Deadline: 30 September 2026)
• Recent Advances in Benign Hematology (Deadline: 30 September 2026)
• Cellular and Molecular Mechanisms of Plaque Development and Progression (Deadline: 30 September 2026)
• Molecular Basis of Hepatic Encephalopathy: From Experimental to Translational Research (Deadline: 30 September 2026)
• Cellular Plasticity and Tissue Remodeling in Chronic Diseases and Cancer (Deadline: 30 September 2026)
• Molecular Diagnostics and Therapeutic Advances in Hematology: From Mechanisms to Clinical Applications (Deadline: 30 September 2026)
• Molecular Biomarkers for Cardiovascular and Renal Disease Risk Prediction (Deadline: 30 September 2026)
• Molecular Pathology Techniques to Define Target Safety Risks for Novel Therapeutic Modalities (Deadline: 30 September 2026)
• Arterial Hypertension: Renal Mechanisms, Metabolic Drivers, and Organ-Protective Strategies (Deadline: 30 September 2026)
• Inflammatory Bowel Disease and Cardiometabolic Comorbidities: Molecular Mechanisms and Therapeutic Perspectives (Deadline: 30 September 2026)
• Molecular Insights into Nanoparticles–Glioma Interactions for Diagnosis and Therapy (Deadline: 30 September 2026)
• Molecular Mechanisms and Treatments in Respiratory Diseases (Deadline: 30 September 2026)
• Inflammatory Bowel Disease: Pathogenesis and Treatment Advances (Deadline: 30 September 2026)
• Emerging Challenges for Renal Health-Biomarkers and Vulnerability to Xenobiotics (Deadline: 30 September 2026)
• Molecular Mechanisms and Therapy of Heart Failure (Deadline: 10 October 2026)
• Multi-Omics Insights into Cardiovascular and Cerebrovascular Diseases (Deadline: 10 October 2026)
• Molecular Precision Medicine: Unraveling Novel Mechanisms and Delivery Strategies in Complex Diseases (Deadline: 20 October 2026)
• New Therapies and Strategies in the Treatment of Neurodegenerative Diseases (Deadline: 20 October 2026)
• Molecular Mechanisms and Therapies for Melanoma (Deadline: 20 October 2026)
• Mitochondrial Disorders: From Molecular Mechanisms to New Therapies (Deadline: 20 October 2026)
• Investigating Gut Axes: Pathophysiological Functions and Therapeutic Strategies (Deadline: 20 October 2026)
• Oxidative Stress Responses in Cardiovascular Diseases (Deadline: 20 October 2026)
• Molecular Advances in Brain Plasticity (Deadline: 20 October 2026)
• Advancements in Hematology: Molecular Biology and Targeted Therapies (Deadline: 20 October 2026)
• Cutaneous Biology, Molecular Dermatology and Dermatopathology, 2nd Edition (Deadline: 20 October 2026)
• Recent Advances in Osteoarthritis Pathways and Biomarker Research (Deadline: 20 October 2026)
• Molecular Insights and Treatments for Gynecological Cancers (Deadline: 20 October 2026)
• Recent Molecular Research in Colitis (Deadline: 20 October 2026)
• P53 and Tumours: Strategies to Overcome Chemoresistance in a p53-Dependent Way (Deadline: 20 October 2026)
• The Impact of Circulating Biomarkers and Metabolites on Cardiometabolic Disease and Cancer: New Insights and Therapeutic Opportunities (Deadline: 20 October 2026)
• Molecular Pathogenesis and Therapeutic Innovations in Oral Diseases (Deadline: 20 October 2026)
• Neural Stem Cells as Tools for Therapies: Challenges and Future Perspectives (Deadline: 20 October 2026)
• Exploring Molecular Insights in Oral Health and Disease (Deadline: 20 October 2026)
• Molecular Mechanisms of SARS-CoV-2 Infection and Pathogenesis (Deadline: 20 October 2026)
• Molecular Pathologies and Treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome—2nd Edition (Deadline: 20 October 2026)
• Molecular Mechanisms and Therapeutic Strategies for Oral Mucosal Diseases: From Radiotherapy-Induced Damage to Other Pathologies (Deadline: 20 October 2026)
• Relationships Between Diabetic Retinal Neuropathies and Vascular Pathologies in Diabetic Retinopathy (Deadline: 20 October 2026)
• Molecular Research in Orofacial Pain and Headache (Deadline: 20 October 2026)
• Eye Diseases: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 23 October 2026)
• Inflammatory Bowel Disease: Molecular Insights—2nd Edition (Deadline: 23 October 2026)
• Molecular Mechanisms of Hematologic Disorders (Deadline: 23 October 2026)
• Targeted Therapy for Breast and Gynecological Cancer (Deadline: 23 October 2026)
• Molecular Research Advances in Common and Rare Pediatric Diseases (Deadline: 23 October 2026)
• Molecular Mechanisms and Intervention Strategies in Cardiovascular and Cerebrovascular Diseases (Deadline: 28 October 2026)
• The Roles of Oxidative Stress in Metabolic Syndrome (Deadline: 30 October 2026)
• Melanin Pigmentation: Physiology and Pathology (Deadline: 30 October 2026)
• Molecular Research in Skin Health and Disease (Deadline: 30 October 2026)
• Molecular and Cellular Therapeutics for Respiratory Diseases (Deadline: 30 October 2026)
• Arthritis: From Molecular Basis to Therapy (Deadline: 30 October 2026)
• Alcohol Use Disorder: From Molecular Mechanisms to Therapeutics (Deadline: 30 October 2026)
• Advances in Lipedema: Pathophysiology, Prevention and Treatments (Deadline: 30 October 2026)
• The Zebrafish Model in Animal and Human Health Research, 3rd Edition (Deadline: 30 October 2026)
• Molecular Pathology, Diagnosis and Therapeutic Strategies of Thrombotic Diseases (Deadline: 30 October 2026)
• Research Advances in Photodynamic Therapy (Deadline: 30 October 2026)
• Advances in Lupus Erythematosus and Lupus Nephritis: Pathogenesis, Biomarkers and Treatments, 2nd Edition (Deadline: 30 October 2026)
• Molecular Mechanism in Pulmonary Embolism (Deadline: 30 October 2026)
• Advances in Molecular Therapeutics for Retinal Disease (Deadline: 30 October 2026)
• Novel Biomarkers for Disease Prediction and Prognosis: Inflammatory, Metabolic and Composite Profiles (Deadline: 30 October 2026)
• Molecular Perspectives on Rare Diseases (Deadline: 30 October 2026)
• The Role of Cytokines in Health and Diseases: Second Edition (Deadline: 30 October 2026)
• Molecular Insights into Cardiovascular Disease (Deadline: 30 October 2026)
• Co-Infections in Parasitic Diseases: Molecular Mechanisms, Diagnostic Challenges, and Therapeutic Strategies (Deadline: 30 October 2026)
• Molecular Biomarkers, Nutritional Status, and Immune Regulation in Gut and Lung Diseases (Deadline: 30 October 2026)
• New Insights into Molecular Mechanisms of Chronic Kidney Disease (Deadline: 31 October 2026)
• The Molecular Network, Key Biomarkers, and Therapeutic Targets in Colorectal Cancer (Deadline: 31 October 2026)
• Molecular Research on Endothelial Cell Injury and Repair (Deadline: 31 October 2026)
• Advances in Laboratory Animal Research for Precision Medicine in Cardiovascular Diseases (Deadline: 31 October 2026)
• Molecular Insights into Liver Disease: Pathogenesis, Progression, and Therapeutic Strategies (Deadline: 31 October 2026)
• Molecular Research on Andrology (Deadline: 31 October 2026)
• Unravelling Functional Biology in Retinal Dystrophies and Eye Disease (Deadline: 31 October 2026)
• Molecular Progress of Cardiovascular and Metabolic Disease (Deadline: 31 October 2026)
• Molecular Pathways to Infertility (Deadline: 31 October 2026)
• Molecular Mechanisms and Pathophysiology of Sepsis (2nd Edition) (Deadline: 31 October 2026)
• Molecular Insights and Novel Therapeutics in Chronic Kidney Disease (Deadline: 31 October 2026)
• Cardiovascular Diseases: From Molecular Mechanisms to Therapeutics (Deadline: 31 October 2026)
• From Molecular Mechanisms to Precision Medicine in Gastrointestinal Cancers: (Epi)genetics, Pharmacogenomics, and Emerging Biomarkers (Deadline: 31 October 2026)
• Progress in Photobiomodulation Therapy (Deadline: 31 October 2026)
• Cold Atmospheric Plasma Effect on Cancer Cells (Deadline: 31 October 2026)
• Mesenchymal Stromal/Stem Cells (MSCs) in Regenerative Medicine (Deadline: 31 October 2026)
• Molecular Mechanisms and Therapeutic Approaches in Glaucoma and Retinal Neurodegeneration (Deadline: 31 October 2026)
• Precision Medicine and Rare Cancers (Deadline: 31 October 2026)
• Molecular Mechanisms and Therapeutics in Chronic Kidney Diseases (Deadline: 31 October 2026)
• Molecular Mechanisms of Environment-Induced Human Diseases (Deadline: 31 October 2026)
• Respiratory Tract Infections: Molecular Pathogenesis, Advanced Diagnostics, and Translational Strategies (Deadline: 31 October 2026)
• Congenital Heart Disease: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 31 October 2026)
• Pathophysiology and Treatments of Spinal Cord Injury (Deadline: 31 October 2026)
• Heart Failure: From Pathophysiology to Therapeutic Targets (Deadline: 31 October 2026)
• Novel Molecular Targets and Prognostic Markers Focused on Improving Quality in Healthcare, 2nd Edition (Deadline: 31 October 2026)
• Ophthalmology: New Molecular Insights and Therapeutic Strategies (Deadline: 31 October 2026)
• Targeted Lipidomics Approaches in Cardiometabolic Diseases: From Sample Preparation to Data Interpretation for Combined Multiomics Analysis (Deadline: 31 October 2026)
• Spatial Multi-Omics: From Molecular Maps to Precision Medicine (Deadline: 31 October 2026)
• Molecular Research on Ischemia-Reperfusion Injury (Deadline: 31 October 2026)
• Heart Diseases: Molecular Research and Novel Therapies (Deadline: 31 October 2026)
• Natural Products and Functional Biomaterials in Wound Healing and Cancer Treatment (Deadline: 31 October 2026)
• Acute Lymphoblastic Leukemia (ALL): From Molecular Drivers to Therapeutic Innovation (Deadline: 31 October 2026)
• Amyotrophic Lateral Sclerosis: From Molecular Basis to Therapies (Deadline: 20 November 2026)
• Glioblastoma: Molecular Pathogenesis and Treatment (Deadline: 20 November 2026)
• Molecular Research on Dyslipidemia (Deadline: 20 November 2026)
• ErbB Family of Receptor Tyrosine Kinases in Cancer and Drug Therapy (Deadline: 20 November 2026)
• The Involvement of the Ubiquitin Proteasome System in the Healthy and Diseased Heart (Deadline: 20 November 2026)
• Dermatology: Advances in Pathophysiology and Therapies (3rd Edition) (Deadline: 20 November 2026)
• Tau Pathology Mechanisms and Therapeutic Interventions (Deadline: 20 November 2026)
• Molecular Insights into Cardiomyopathy (Deadline: 20 November 2026)
• Flow Cytometry as a Tool for Diagnostics and Biomarker Research (Deadline: 20 November 2026)
• The Impact of the Exposome on Gut Health: Deciphering Molecular Mechanisms and Pathophysiological Pathways (Deadline: 20 November 2026)
• Molecular Understanding Involved in Age-Related Diseases (Deadline: 20 November 2026)
• Recent Approaches for Wound Treatment: 3rd Edition (Deadline: 27 November 2026)
• Current Research for Heart Disease Biology and Therapeutics: Fourth Edition (Deadline: 29 November 2026)
• Molecular Studies in Aging, 2nd Edition (Deadline: 30 November 2026)
• Molecular Diagnosis and Treatment in Cardiovascular Diseases (Deadline: 30 November 2026)
• Steatotic Liver Disease: From Bench to Bedside and Back (Deadline: 30 November 2026)
• The Latest Molecular Research on Renal Disease (Deadline: 30 November 2026)
• New Insights into the Molecular Pathogenesis of Myeloproliferative Neoplasms (Deadline: 30 November 2026)
• Ovarian Pathologies: Insights into Mechanisms and Therapeutic Strategy (Deadline: 30 November 2026)
• Molecular Research of Cardiovascular Disease (Deadline: 30 November 2026)
• Current Advances in the Pathophysiology and Treatment of Multiple Sclerosis and Related Disorders (Deadline: 30 November 2026)
• Cellular and Molecular Biology of Cardiac Hypertrophy and Heart Failure: Pathogenesis, Diagnostics and Treatment—2nd Edition (Deadline: 30 November 2026)
• Hemolytic Anemia: From Molecular Mechanisms to Therapeutic Exploitation (Deadline: 30 November 2026)
• Lifestyle Interventions in MASLD: Molecular and Clinical Perspectives (Deadline: 30 November 2026)
• Molecular Pathology and Next-Generation Biomarkers in Nephrology (Deadline: 30 November 2026)
• The Roles of Diet and Nutrition in Metabolic Diseases: Advancements in Molecular Insights (Deadline: 30 November 2026)
• Cellular and Molecular Mechanisms in Inflammatory Bowel Disease (Deadline: 30 November 2026)
• Advanced Molecular Research in Cardiology and Treatment Approaches (Deadline: 30 November 2026)
• Molecular Mechanisms of Skeletal Muscle Adaptation (Deadline: 30 November 2026)
• Molecular Mechanisms of Environmental Stress-Induced Human Diseases (Deadline: 30 November 2026)
• Molecular Research in Leukemia (Deadline: 30 November 2026)
• Molecular Research on Ataxia (Deadline: 30 November 2026)
• Chronic Kidney Disease: Underlying Molecular Mechanisms—2nd Edition (Deadline: 30 November 2026)
• Gastrointestinal Inflammation: From Pathogenesis to Molecular Diagnosis and Treatment (Deadline: 30 November 2026)
• Natural Products as Therapeutic Agents: From Molecular Targets to Cellular and Functional Modulation (Deadline: 30 November 2026)
• Emerging Technologies in Musculoskeletal Research: From Molecular Mechanisms to Translational Innovation (Deadline: 30 November 2026)
• Gene Therapy for Ocular Diseases: Mechanisms, Advances and Therapeutic Applications (Deadline: 30 November 2026)
• From Biology to Biomechanics: Molecular Advances in Orthodontic Remodeling and Acceleration (Deadline: 30 November 2026)
• Cardiovascular Diseases: Histopathological and Molecular Diagnostics, 2nd Edition (Deadline: 30 November 2026)
• Molecular Insights into Amyotrophic Lateral Sclerosis (Deadline: 30 November 2026)
• Skeletal Muscle Aging: Mechanisms, Biomarkers, and Interventions (Deadline: 30 November 2026)
• Therapeutic Strategies for Surgical Tissue Damage, Repair and Regeneration (Deadline: 30 November 2026)
• Molecular Insights in Women’s Health: Advances in Gynecological Disease Mechanisms and Therapeutics (Deadline: 30 November 2026)
• Metabolic Diseases: From Molecular Mechanisms to Innovative Therapeutics (Deadline: 30 November 2026)
• Molecular and Cellular Mechanisms in Amyotrophic Lateral Sclerosis (Deadline: 30 November 2026)
• Musculoskeletal Development and Skeletal Pathophysiologies, 3rd Edition (Deadline: 30 November 2026)
• Molecular and Translational Research in Cardiovascular Endocrinology, Cardiovascular–Kidney–Metabolic Diseases and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): 3rd Edition (Deadline: 30 November 2026)
• Microbial Involvement in Cancer: Stem Cell Regulation, Immunity, and Therapy Response (Deadline: 30 November 2026)
• Molecular Mechanisms, Epigenetics and Therapeutics in Liver Cirrhosis (Deadline: 30 November 2026)
• Molecular Advances in Zoonoses and Vector-Borne Diseases (Deadline: 30 November 2026)
• Molecular Research of Gastrointestinal Disease, 3rd Edition (Deadline: 30 November 2026)
• Dietary Interventions for Type 2 Diabetes: Current Evidence and Emerging Perspectives on Underlying Molecular Mechanisms (Deadline: 30 November 2026)
• New Perspectives in Cardiovascular Disease: From Molecular Mechanisms to Clinical Innovations (Deadline: 30 November 2026)
• Epigenetic Mechanisms in Human Diseases: From Molecular Pathogenesis to Therapeutic Interventions (Deadline: 30 November 2026)
• Advances in Lung Research: From Mechanisms to Therapeutic Innovation (Deadline: 30 November 2026)
• Heart Failure: New Paradigms in Molecular Pathology and Mechanistic Regulation (Deadline: 30 November 2026)
• New Insights into Allergic Asthma (Deadline: 30 November 2026)
• Current Research on Skin Pigmentation and Photoaging (Deadline: 30 November 2026)
• Translational Insights in Solid Tumors: Bridging Molecular Mechanisms to Therapeutic Advances (Deadline: 30 November 2026)
• Molecular Insights in Cardiovascular Disease (Deadline: 30 November 2026)
• Molecular Diagnosis and Treatments of Diabetes Mellitus: 3rd Edition (Deadline: 30 November 2026)
• Molecular and Cellular Mechanisms in Fibrotic Interstitial Lung Diseases (Deadline: 30 November 2026)
• Molecular Advances in the Diagnosis and Treatment of Cardiovascular Disease and Diabetes Mellitus (Deadline: 30 November 2026)
• Molecular Research on Skin Inflammation (2nd Edition) (Deadline: 30 November 2026)
• Liver Fibrosis: Molecular Pathogenesis, Diagnosis and Treatment—2nd Edition (Deadline: 30 November 2026)
• Molecular Research Advances in HIV Infection (Deadline: 30 November 2026)
• Kidney Disease: From Biomarkers, Molecular Mechanisms to Targeted Therapy (Deadline: 30 November 2026)
• Pediatric Diseases: From Molecular Mechanisms to Novel Therapeutic Strategies—2nd Edition (Deadline: 30 November 2026)
• Molecular Advances in Periodontitis (Deadline: 30 November 2026)
• Mesenchymal Stromal Cells Within the Tissue Microenvironment: Translational Research and Therapeutic Perspectives (Deadline: 30 November 2026)
• Stem Cells, Biomaterials, and Molecular Therapies in Plastic Surgery (Deadline: 5 December 2026)
• Musculoskeletal Disorders: From Molecular Pathology to Novel Therapeutic Approach—2nd Edition (Deadline: 15 December 2026)
• Research in Alzheimer’s Disease: Advances and Perspectives (Deadline: 20 December 2026)
• Exosomes and Non-Coding RNA Research in Health and Disease—2nd Edition (Deadline: 20 December 2026)
• From Molecular Mechanisms to Patient Related Outcomes: Advances in Spinal Muscular Atrophy Research and Care (Deadline: 20 December 2026)
• Understanding Allergy and Asthma at the Molecular Level (Deadline: 25 December 2026)
• Molecular Therapeutics for Diabetes and Related Complications, 2nd Edition (Deadline: 25 December 2026)
• Inflammatory Bowel Disease: Pathogenesis and Novel Therapeutic Approaches (Deadline: 25 December 2026)
• Pain in Human Health and Disease (Deadline: 25 December 2026)
• Advances in Pulmonary Hypertension and Interstitial Lung Diseases: Mechanisms and Treatments (Deadline: 25 December 2026)
• Molecular Biomarkers for Assessing Marine Ecosystem Health (Deadline: 25 December 2026)
• Molecular Mechanisms of Reproduction and Reproductive Diseases (Deadline: 25 December 2026)
• Liver Diseases: Causes, Molecular Mechanism and Treatment/Prevention (Deadline: 25 December 2026)
• Molecular Biology of 3D Cell and Tissue Culture Systems: Benefits to Research and Disease Diagnostics (Deadline: 25 December 2026)
• Molecular Interplay Between Aging, Dementia and Renal Function: Mechanisms, Biomarkers and Therapeutic Targets (Deadline: 25 December 2026)
• Targeting MAPK in Human Diseases (Deadline: 25 December 2026)
• Biomarkers in Diabetes Mellitus: From Discovery to Clinical Application (Deadline: 25 December 2026)
• MicroRNAs in Physiology and Pathophysiology (Deadline: 25 December 2026)
• Molecular and Clinical Advances in Ophthalmic Inflammation, Infection, and Degeneration (Deadline: 25 December 2026)
• Recent Advances in Dementia with Lewy Bodies and Alzheimer’s Disease (Deadline: 25 December 2026)
• Atherosclerosis and Comorbidities: From Molecular Pathogenesis to Diagnosis and Therapeutic Targets (Deadline: 25 December 2026)
• Advancements in Inflammatory and Oxidative Disease Research (Deadline: 25 December 2026)
• Computational and Molecular Advances in Precision Craniofacial Medicine (Deadline: 25 December 2026)
• Mitochondrial Dysfunction and Oxidative Stress in Human Diseases (Deadline: 25 December 2026)
• Highlights in Pathophysiology of the Musculoskeletal System, 3rd Edition (Deadline: 25 December 2026)
• Drug and Non-Drug Treatment of Cerebral Diseases (Deadline: 25 December 2026)
• Molecular Mechanisms and Therapeutic Targets in Cardiovascular Health and Cardiotoxicity (Deadline: 25 December 2026)
• Diversity in Structure, Function, and Regulation of Calcium-Permeable Channels (Deadline: 25 December 2026)
• Progress in Prevention and Treatment of Cardiovascular Diseases and Arrhythmias (Deadline: 25 December 2026)
• Advancements in Cardiovascular Health Research: Investigating Novel Biomaterials, Cellular Responses and Therapies (Deadline: 25 December 2026)
• Machine Learning in Disease Diagnosis and Treatment: 2nd Edition (Deadline: 25 December 2026)
• Molecular Insights into Ophthalmic Diseases (Deadline: 25 December 2026)
• Advances in Angiogenesis: From Molecular Insights to Therapeutic Strategies (Deadline: 25 December 2026)
• Liver Disease and Primary Liver Cancer: Translational Advances and Therapeutic Perspectives (Deadline: 25 December 2026)
• Molecular Biology, Genetics, Diagnosis, Management and Therapy of Dermatological Diseases (Deadline: 25 December 2026)
• Molecular Mechanisms and Treatment Strategies in Diabetic Kidney Disease (Deadline: 25 December 2026)
• The Role of Complement Regulation in Kidney Disease (Deadline: 25 December 2026)
• Inflammatory Bowel Disease: Molecular Advances in Pathogenesis and Therapies, 2nd Edition (Deadline: 25 December 2026)
• Molecular and Cellular Mechanisms of Myocardial Disease (Deadline: 25 December 2026)
• Biomolecular Stratification in Antiphospholipid Syndrome (Deadline: 25 December 2026)
• The Next Chapter in HIV: Molecular Pathways and Novel Therapeutic Strategies (Deadline: 25 December 2026)
• Recent Research on Metabolomics and Cancer Pathogenesis (Deadline: 25 December 2026)
• Unravelling Molecular Pathways in Ocular Disease and Degeneration (Deadline: 25 December 2026)
• From ER Stress to Clinical Biomarkers: Integrating Mechanistic Understanding with Diagnostic Innovation (Deadline: 25 December 2026)
• Molecular Epidemiology, Surveillance, and Control of Infectious Diseases: From Pathogen Genomics to Public Health Action (Deadline: 25 December 2026)
• Molecular Biomarkers for Targeted Therapies: 2nd Edition (Deadline: 25 December 2026)
• Inflammatory Microenvironments in Chronic Diseases: Immune Regulation, Tissue Adaptation, and Molecular Remodeling (Deadline: 28 December 2026)
• Mechanisms of Exercise Training on Vascular Disease (Deadline: 28 December 2026)
• Advances in the Pathology and Pathogenetic Mechanisms of Diabetic Neuropathy (Deadline: 30 December 2026)
• Osteoporosis: From Molecular Research to Novel Therapies (Deadline: 31 December 2026)
• Environmental Sensitivity Illnesses: Advances in Mechanisms and Molecular Signatures (Deadline: 31 December 2026)
• Molecular Mechanisms Linking Obesity to Atherosclerosis Pathogenesis (Deadline: 31 December 2026)
• Highlights in Pathophysiology and Treatment of Osteoarthritis (Deadline: 31 December 2026)
• Autosomal Dominant Polycystic Kidney Disease (ADPKD): Molecular Mechanism, Management and Therapy (Deadline: 31 December 2026)
• Sex and Gender Medicine—Physiology: A New Horizon in Human Physiology (Deadline: 31 December 2026)
• Molecular Basis and Treatment of Skin Diseases and Their Associated Complications (2nd Edition) (Deadline: 31 December 2026)
• Breast Cancer and Molecular-Based Treatments (Deadline: 31 December 2026)
• Molecular Mechanisms in Cardiovascular Disease Progression (Deadline: 31 December 2026)
• Molecular Research and Advances in Ocular Disease (Deadline: 31 December 2026)
• Cellular Mechanisms of Pulmonary Arterial Hypertension (Deadline: 31 December 2026)
• Molecular Advances in the Pathophysiology and Therapy of Cerebral Gliomas (Deadline: 31 December 2026)
• Pulmonary Fibrosis: Molecular Mechanisms and Therapeutic Strategies (Deadline: 31 December 2026)
• Viral Biology: Infection and Pathology, Diagnosis and Treatment (Deadline: 31 December 2026)
• Advances in HIV Research: Molecular Basis and Potential Therapies (Deadline: 31 December 2026)
• Molecular Advances on Sickle Cell Disease (Deadline: 31 December 2026)
• Molecular Advances in Obstetrical and Gynaecological Disorders: 2nd Edition (Deadline: 31 December 2026)
• Oral Diseases and Oral Soft Tissue Repair (Deadline: 31 December 2026)
• Individualised Therapies for Rare Disorders (Deadline: 31 December 2026)
• Ovarian Insufficiency: From Molecular Pathology to Novel Therapeutic Approach (Deadline: 31 December 2026)
• Molecular and Translational Mechanisms of Cardiac Arrhythmias: From Oxidative Stress to Novel Therapeutic Strategies (Deadline: 31 December 2026)
• Emerging Biomarkers of Inflammation and Cancer: From Molecular Pathways to Clinical Stratification (Deadline: 31 December 2026)
• Mechanisms of Pain Development and Treatment Strategies (Deadline: 31 December 2026)
• Genetic and Metabolic Liver Disorders: Advances in Diagnosis, Disease Mechanisms and Treatment (Deadline: 31 December 2026)
• Molecular Pathogenesis of Common Pregnancy Complications (Deadline: 31 December 2026)
• Molecular Mechanisms and Therapeutic Implications in Cardiovascular Diseases (Deadline: 31 December 2026)
• Molecular Mechanisms and Therapeutic Innovations in Hypercholesterolemia and Dyslipidemia (Deadline: 31 December 2026)
• Leishmaniasis: Pathogenesis and Emerging Therapeutic Strategies (Deadline: 31 December 2026)
• Molecular Insights into Hormonal Disturbances in Respiratory Disorders (Deadline: 31 December 2026)
• Spinal Muscular Atrophy: From Genetics to Therapeutics (Deadline: 31 December 2026)
• Bridging Molecular and Translational Research in Chronic Kidney Disease and Dysmetabolism (Deadline: 31 December 2026)
• Coronavirus Disease (COVID-19): Pathophysiology (7th Edition) (Deadline: 31 December 2026)
• Idiosyncratic Drug Induced Liver Injury (Deadline: 31 December 2026)
• Molecular Complexity of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Bench to Clinical Practice (Deadline: 31 December 2026)
• Cholangiocarcinoma: Molecular Diagnosis and Future Therapeutic Perspectives (Deadline: 31 December 2026)
• Molecular Mechanisms of Hypertension (Deadline: 29 January 2027)
• Molecular Mechanisms Underlying Glomerular and Tubular Kidney Diseases (Deadline: 29 January 2027)
• Exosomes and Extracellular Vesicles in Health and Diseases: 4th Edition (Deadline: 30 January 2027)
• Molecular Mechanisms and Therapeutic Targeting of Inflammatory Complications—2nd Edition (Deadline: 30 January 2027)
• Oxidative Stress in Disease: From Biomarkers to Clinical Translation (Deadline: 30 January 2027)
• Analysis on Effector and Regulatory Molecules in Renal Diseases (Deadline: 31 January 2027)
• Innovative Molecular Target and Therapeutic Approaches in Fatty Liver Disease (Deadline: 31 January 2027)
• The Role of Lipoprotein in Cardiovascular Disease (Deadline: 31 January 2027)
• Molecular Advances in Primary Colorectal Cancer and Liver Metastases (Deadline: 31 January 2027)
• Heart Failure: From Pathogenesis to Innovative Treatments (Deadline: 31 January 2027)
• mRNA/miRNAs Network in Diabetes and Its Complications (Deadline: 31 January 2027)
• Novel Genotypes and Experimental Advances in Xenotransplantation (Deadline: 31 January 2027)
• Advances in Male Infertility and Fertility (Deadline: 31 January 2027)
• Bone Metabolism and Bone Diseases (Deadline: 31 January 2027)
• Molecular Horizons in Pain Therapeutics (Deadline: 31 January 2027)
• Colorectal Cancers: New Approach to Their Pathology, Diagnosis and Therapy (Deadline: 31 January 2027)
• New Insights into Adipose Tissue Metabolic Function and Dysfunction, 4th Edition (Deadline: 31 January 2027)
• Targeting Cancer Metabolism: From Mechanism to Therapies (Deadline: 31 January 2027)
• Current and Emerging Therapeutic Approaches for MASLD (Deadline: 31 January 2027)
• Molecular Mechanisms of Parasitic Diseases (Deadline: 31 January 2027)
• Molecular Mechanisms and Treatment in Gastrointestinal Cancers (Deadline: 31 January 2027)
• Non-Coding RNAs’ Functionality—Diagnosis and Therapy in Cancer and Other Indications (2nd Edition) (Deadline: 31 January 2027)
• Advancing Molecular Science Through Reproducible qPCR: MIQE Guidelines and Beyond (Deadline: 31 January 2027)
• Animal Models for Human Diseases (Deadline: 31 January 2027)
• Infectious Diseases and Infection Models in Laboratory Animals (Deadline: 31 January 2027)
• Male Reproduction: Unveiling the Molecular Revolution (Deadline: 31 January 2027)
• Molecular Mechanisms and Diagnostics in Hereditary Hemolytic Anemias (Deadline: 31 January 2027)
• The Molecular and Cellular Pathophysiologic Mechanisms Underlying Ocular Diseases and Emerging Therapies (2nd Edition) (Deadline: 31 January 2027)
• Melanoma: From Molecular Pathology to Therapeutic Approaches, 2nd Edition (Deadline: 31 January 2027)
• Research Progress in Cellular Senescence in Health and Disease (Deadline: 31 January 2027)
• Systemic Lupus: Molecular Research, New Biomarkers and Novel Therapy (Deadline: 31 January 2027)
• Natural Products and Drug Delivery Systems in Dental Diseases (Deadline: 31 January 2027)
• Molecular Mechanisms of Cardiac Development and Disease (Second Edition) (Deadline: 31 January 2027)
• Innovative Strategies and Molecular Insights Into Wound Healing (Deadline: 31 January 2027)
• Angiogenesis: Mechanisms and Targets in a Wide Spectrum of Diseases (Deadline: 31 January 2027)
• Molecular Mechanisms of Human Liver Diseases: 3rd Edition (Deadline: 31 January 2027)
• Novel Advances in Ataxia-Telangiectasia (Deadline: 31 January 2027)
• Exploring the Gut-Brain Axis: Mechanisms and Implications for Health and Disease (Deadline: 31 January 2027)
• Molecular Crosstalk in Allergy, Barrier Dysfunction, and Asthma (Deadline: 31 January 2027)
• Emerging Biomarkers in Cardiovascular Risk Assessment and Myocardial Injury (Deadline: 31 January 2027)
• Targeted Molecular Radio-Immuno-Theranostics: From Cancer to Other Human Diseases—in Honor of Prof. Dr. Otmar Dieter Wiestler (Deadline: 31 January 2027)
• Atherosclerosis: From Molecular Biology to Therapeutic Perspective: 7th Edition (Deadline: 31 January 2027)
• Role of Proteomics in Human Diseases and Infections: 2nd Edition (Deadline: 31 January 2027)
• Retinal Degeneration: From Pathophysiology to Therapeutic Approaches—4th Edition (Deadline: 31 January 2027)
• Advances in Molecular Pathology and Treatment of Breast Cancer (Deadline: 31 January 2027)
• Organoid Models: Advancing the Study of Disease Mechanisms and Nutritional Regulations (Deadline: 31 January 2027)
• Advances in Retinal Diseases: 3rd Edition (Deadline: 31 January 2027)
• Autophagy in Physiology and Pathophysiology: Recent Advances (Deadline: 31 January 2027)
• Identification of Molecular Biomarkers Through Digital Pathology (Deadline: 31 January 2027)
• New Perspectives and Challenges in the Mechanisms, Diagnosis and Management of Skin Diseases (Deadline: 31 January 2027)
• Bridging Basic and Clinical Science: Shared Molecular and Metabolic Mechanisms in Preeclampsia, Gestational Diabetes and Gestational Weight Gain (Deadline: 31 January 2027)
• Molecular Mechanisms of Chronic Lung Diseases (Deadline: 31 January 2027)
• New Advances in Thrombosis: 4th Edition (Deadline: 31 January 2027)
• Molecular Perspectives in Lung Diseases: Pathogenesis, Diagnosis, and Treatment—2nd Edition (Deadline: 31 January 2027)
• Molecular Biomarkers in Oral Pathology (Deadline: 31 January 2027)
• Molecular Insights into Stroke: Biomarkers and Mechanisms (Deadline: 31 January 2027)
• Advances in Cardiovascular Disease: Pathophysiology, Diagnosis, and Therapy (Deadline: 31 January 2027)
• Advances in Photodynamic Therapy and Photodetection: Targeted Approaches and Immunological Perspectives (Deadline: 31 January 2027)
• Lysosomal Storage Disorders: Molecular Pathogenesis and Next-Generation Therapeutics (Deadline: 31 January 2027)
• Latest Advances in Targeted Molecular Therapies for Genetic Disease (Deadline: 31 January 2027)
• The Application of Stem Cells in Regenerative Medicine (Deadline: 31 January 2027)
• Bridging Molecular Endotypes and Clinical Phenotypes in Sleep Apnea-From Mechanistic Insights to Precision Therapeutics (Deadline: 31 January 2027)
• Pathological Changes and Pathogenic Mechanisms of Chronic Liver Disease (Deadline: 31 January 2027)
• Unknown Pathogenesis of Musculoskeletal Diseases and Basic Sciences: The Role of New Technologies (Deadline: 31 January 2027)
• Mesenchymal Stem Cell-Derived Extracellular Vesicles as Therapeutic Tools in Chronic Diseases (Deadline: 31 January 2027)
• Rheumatic Diseases: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 31 January 2027)
• Molecular Mechanisms and Therapeutic Innovations in Urological Cancers (Deadline: 31 January 2027)
• Thyroid Disorders: From Physiological Regulation to Targeted Cancer Therapy (Deadline: 31 January 2027)
• The Molecular Basis of Vascular Pathology: 2nd Edition (Deadline: 31 January 2027)
• Kidney Diseases: Molecular Mechanisms and Therapies (Deadline: 31 January 2027)
• Novel Therapeutic Strategies for Cystic Fibrosis (Deadline: 31 January 2027)
• Targeting the Renin–Angiotensin System: A Molecular Strategy for Disease Intervention (Deadline: 31 January 2027)
• Acute Kidney Injury: From Pathogenesis to Targeted Therapy (Deadline: 31 January 2027)
• Mitochondrial Dysfunction and Chronic Diseases: Molecular Insight and Therapeutic Opportunities (Deadline: 31 January 2027)
• Rare Genetic Diseases: From Molecular Mechanisms to Therapeutic Strategies—2nd Edition (Deadline: 31 January 2027)
• Chronic Stress, Neuroinflammation and Pain: Molecular Mechanisms, Biomarkers and Precision Therapies (Deadline: 31 January 2027)
• Ventricular Function and Pathophysiology in Cardiovascular Diseases (Deadline: 31 January 2027)
• Mechanisms of Cardiotoxicity in Anticancer Therapies (Deadline: 31 January 2027)
• Pathophysiology and Therapeutic Targets in Cardiovascular Disease (Deadline: 31 January 2027)
• Oxidative Stress in Human Diseases: Molecular Mechanisms, Biomarkers, and Therapeutic Perspectives (Deadline: 31 January 2027)
• Recent Advances in Systemic Lupus Erythematosus Pathogenesis (Deadline: 31 January 2027)
• Gastrointestinal Injury and Inflammation: Molecular Mechanisms and Therapeutic Insights (Deadline: 31 January 2027)
• Molecular Therapeutic Mechanisms and Drug Discovery for Obesity and Nephropathy (Deadline: 31 January 2027)
• Molecular Mechanisms of Chronic Obstructive Pulmonary Disease (COPD): From Pathogenesis to Therapeutic Response (Deadline: 31 January 2027)
• Molecular Insights into Pediatric Kidney Diseases: From Development to Disease and Therapy (Deadline: 31 January 2027)
• Acquired Macular Diseases: New Systemic/Ocular Biomarkers and Novel Pharmacological Targets (Deadline: 31 January 2027)
• Synthetic Lethality and Genome Stability in Cancer: From Molecular Mechanisms to Precision Therapy (Deadline: 31 January 2027)
• Diagnosis and Treatment of Diabetes and Its Complications (Deadline: 31 January 2027)
• Interplay Between the Human Microbiome and Diseases, 2nd Edition (Deadline: 31 January 2027)
• Cholesterol and Oxysterols as Signaling Molecules in Human Pathophysiology (Deadline: 31 January 2027)
• Advances and Applications of Gold Nanotherapeutics (Deadline: 31 January 2027)
• Precision Cardiovascular Medicine: Molecular Insights and AI-Driven Analytics (Deadline: 31 January 2027)
• Pathogenesis and Antiviral Treatment of Emerging and Reemerging Viral Infections (Deadline: 20 February 2027)
• Sleep Apnea and Sleep-Disordered Breathing (Deadline: 20 February 2027)
• Advances in Molecular Approaches to Asthma Management (Deadline: 28 February 2027)
• Molecular Mechanisms Governing Lipid Metabolism in Health and Disease (Deadline: 28 February 2027)
• Molecular Characterization of Glioblastoma: Implications for Diagnosis and Personalized Treatment (Deadline: 28 February 2027)
• Oxidative and Redox Signalling in Neurological Diseases (Deadline: 28 February 2027)
• Molecular Mechanisms of Nitric Oxide in Cardiovascular System (Deadline: 28 February 2027)
• Molecular Pathology of the Placenta in Pregnancy Complications (Deadline: 28 February 2027)
• Contemporary Perspective of Cardio-Kidney Metabolic Syndrome: From Prevention to Management (Deadline: 28 February 2027)
• Molecular Mechanisms Underlying the Pathogenesis and Treatment of Gastrointestinal Disorders (Deadline: 28 February 2027)
• Molecular Advances in Radiation Oncology: Mechanisms, Immunotherapy and Innovation (Deadline: 28 February 2027)
• Molecular Biology of the Thyroid Cancer and Thyroid Dysfunctions: 2nd Edition (Deadline: 28 February 2027)
• Molecular and Signaling Pathways in Pathological Changes of Esophageal, Gastric and Intestinal Epithelial Cells and Methods of Cell Protective Treatment (Deadline: 28 February 2027)
• Genetic and Metabolic Molecular Research of Lysosomal Storage Disease: 5th Edition (Deadline: 28 February 2027)
• Pulmonary Hypertension: From Molecular Pathophysiology to New Therapeutic Approaches (Deadline: 28 February 2027)
• Molecular, Cellular Mechanisms and Pathophysiology of Glioblastoma (Deadline: 28 February 2027)
• Molecular-Level Insights into Retinal Vascular Disorders (Deadline: 28 February 2027)
• Advanced Molecular Mechanism of Pathogenesis of Osteoarthritis (Deadline: 28 February 2027)
• Molecular Research in Pregnancy-Related Complications (Deadline: 28 February 2027)
• Molecular Insights and Therapeutic Advances in Atherosclerosis (Deadline: 28 February 2027)
• Advances in Biomedical and Tissue Engineering Strategies to Cross the Blood–Brain Barrier for Next-Generation Treatments Against Neurodegenerative Diseases, 2nd Edition (Deadline: 28 February 2027)
• Molecular Studies on Obesity and Related Diseases (Deadline: 28 February 2027)
• Molecular Mechanisms of Dementia and Application of Biomarkers (Deadline: 28 February 2027)
• Polyendocrine-Metabolic-Ovarian Syndrome: Targeted Therapeutics and Future Perspectives (Deadline: 28 February 2027)
• Molecular Mechanisms and Biomarkers of Renal Injury: Bridging the Gap Between Micro-Environment Damage and Clinical Diagnosis (Deadline: 28 February 2027)
• Deciphering the Molecular Mechanisms and Etiology of Thrombosis (Deadline: 28 February 2027)
• Skin Extracellular Matrix and Basement Membrane (Deadline: 28 February 2027)
• Molecular Advances in Oral and Periodontal Health (Deadline: 28 February 2027)
• Cardiovascular and Metabolic Sequelae of Peripheral Artery Disease: From Mechanisms to Therapeutic Targets (Deadline: 28 February 2027)
• Obesity and Its Associated Diseases: Molecular and Metabolic Pathways (Deadline: 28 February 2027)
• Molecular Research in Cerebral Ischemia: From Microglial States to Angiogenic Resilience (Deadline: 28 February 2027)
• New Insights into Retinal Degenerative Diseases (Deadline: 28 February 2027)
• Cellular and Molecular Advances in Cardiac Injury and Repair (Deadline: 28 February 2027)
• Islet Transplantation: Molecular Mechanisms and Translational Approaches (Deadline: 28 February 2027)
• Current Research on the Cellular and Molecular Basis of Allergic Diseases (Deadline: 28 February 2027)
• Regenerative Medicine: Stem Cells, Extracellular Vesicles, Bioinspired Nanovesicles, and Artificial Intelligence for Precision Tissue Repair (Deadline: 28 February 2027)
• Disease Models and Molecular Mechanisms in Cardiovascular Development and Remodeling (Deadline: 28 February 2027)
• Pathogenesis of Endometriosis, Disease Stratification, Diagnosis and Therapy (Deadline: 28 February 2027)
• RNA Regulation and Satellite Cell-Opathies: Molecular Pathogenesis and Therapeutic Frontiers in Neuromuscular Diseases (Deadline: 28 February 2027)
• Oxidative Stress, Inflammation, and Insulin Resistance in Obesity and Metabolic Syndrome (Deadline: 28 February 2027)
• Molecular Innovations and Precision Medicine in Liver Diseases: From Mechanisms to Clinical Practice (Deadline: 28 February 2027)
• Molecular Insights into Metabolic Inflammation in Diabetic Complications, Metabolic Disorders, and Cancer Progression (Deadline: 28 February 2027)
• Hepatopancreatic and Intestine Diseases: From Molecular Basis to Therapy—Mitochondrial Insights (Deadline: 20 March 2027)
• Novel Insights into Cardiac Diseases (Deadline: 30 March 2027)
• Natural Products in Metabolic Diseases: From Molecular Target Discovery to Clinical Translation (Deadline: 30 March 2027)
• Non-Coding RNAs as Key Regulators in Human Disease Processes (Deadline: 31 March 2027)
• Molecular Pathophysiology of Chronic Lung Diseases: Mechanisms and Therapeutics (Deadline: 31 March 2027)
• Fractalkine (CX3CL1) and Its Chemoattractant and Adhesion Molecule Properties in Health and Disease, 2nd Edition (Deadline: 31 March 2027)
• Hidradenitis Suppurativa: Molecular Mechanisms and Therapeutic Strategies (Deadline: 31 March 2027)
• Molecular Insight into Retinal Diseases: 2nd Edition (Deadline: 31 March 2027)
• Advances in Genetic and Epigenetic Research in Skin Diseases (Deadline: 31 March 2027)
• Oxidative Stress and the Kidney: From Physiological Homeostasis to Pathophysiology and Nutraceutical Interventions (Deadline: 31 March 2027)
• Understanding Cardiotoxicity: From Mechanisms to Therapeutic Implications (Deadline: 31 March 2027)
• Molecular and Cellular Mechanisms in the Pathophysiology of Gliomas (Deadline: 31 March 2027)
• Advances in Infectious Disease Detection: Novel Assays and Biomarkers (Deadline: 31 March 2027)
• Molecular Diagnosis and Prevention of Infectious Diseases (Deadline: 31 March 2027)
• New Advances in Protein Analysis in Disease (Deadline: 31 March 2027)
• Molecular Mechanisms in Glomerular and Renal Diseases (Deadline: 31 March 2027)
• Updates on Oral Potentially Malignant Disorders: From Pathogenesis to Treatment (Deadline: 31 March 2027)
• Molecular Research and Biomarkers in Systemic Sclerosis (Deadline: 31 March 2027)
• Targeting KRAS in Thoracic Malignancies (Deadline: 31 March 2027)
• Molecular Insights into Placental Pathology: 2nd Edition (Deadline: 31 March 2027)
• Insights into Cardiotoxicity: From Mechanisms to Therapeutics (Deadline: 31 March 2027)
• Male Infertility: Emerging Trends and Future Directions (Deadline: 29 April 2027)
• Protein–Protein Interactions in Human Cancer (Deadline: 30 April 2027)
• Forward in Vasculitis: Genetics and Beyond, 2nd Edition (Deadline: 30 April 2027)
• Sex and Gender Medicine: New Horizons in Human Health and Disease (Deadline: 30 June 2027)

Topical Collections

Following topical collections within this section are currently open for submissions:

• Cardiomyopathies: Molecular Insights and Future Perspectives
• Feature Papers in Molecular Pathology, Diagnostics, and Therapeutics
• Latest Review Papers in Molecular Pathology, Diagnostics, and Therapeutics
• Molecular Research on Hematologic Diseases
• Molecular Understanding of the Exocrine Pancreas and Its Disorders